Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

Background/Aims: Aspirin has been demonstrated to possess potent chemopreventive and anticancer effects on prostate cancer. However, the more detailed molecular mechanisms of aspirin to suppress prostate cancer cell invasion have not been clearly elucidated. Methods: Transwell assays were performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Chongjun Shi, Nini Zhang, Yang Feng, Jiewei Cao, Xuyi Chen, Bin Liu
Formato: Artículo
Lenguaje:English
Publicado: Cell Physiol Biochem Press GmbH & Co KG 2017-03-01
Colección:Cellular Physiology and Biochemistry
Materias:
Invasion
Matrix metalloproteinase
Nuclear factor-kappa B
Prostate cancer
Urokinase-type plasminogen activator
Acceso en línea:http://www.karger.com/Article/FullText/464434

Internet

http://www.karger.com/Article/FullText/464434

Ejemplares similares